ClinicalTrials.Veeva

Menu

Effect of Emotion-Focused Acceptance and Commitment Therapy on Obsessive-Compulsive Disorder Symptom Severity (ACT-OCD)

M

Mehmet Emrah Karadere

Status

Enrolling

Conditions

OCD
Obsessive - Compulsive Disorder

Treatments

Behavioral: Emotion-Focused Acceptance and Commitment Therapy (ACT) Group Psychotherapy

Study type

Interventional

Funder types

Other

Identifiers

NCT07622654
2026/0040
2025/0040 (Other Identifier)

Details and patient eligibility

About

This study aims to investigate the effect of Emotion-Focused Acceptance and Commitment Therapy (ACT) group psychotherapy on obsessive-compulsive disorder (OCD) symptom severity. Participants with OCD will be randomly assigned to either an ACT-based group psychotherapy arm or a supportive group psychotherapy arm. Each arm consists of 10 to 12 weekly sessions of 2 hours. Symptom severity, psychological flexibility, emotional awareness, functioning and quality of life will be assessed before and after the intervention.

Full description

This randomized controlled trial investigates the efficacy of an Emotion-Focused Acceptance and Commitment Therapy (ACT) protocol in adults diagnosed with Obsessive-Compulsive Disorder (OCD). Participants will be recruited from the psychiatry outpatient clinic of Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi.

Eligible participants will be randomly assigned to one of two arms:

ACT-based group psychotherapy: Structured group therapy targeting emotional awareness, acceptance of emotional experiences, cognitive defusion, present-moment focus, values clarification, and committed action. Groups will consist of 8-10 participants, meeting once weekly for 10-12 sessions of 2 hours each.

Supportive group psychotherapy (active control): Unstructured supportive group therapy aimed at providing emotional support, enhancing coping with stress, and maintaining current functioning. Groups will consist of 8-10 participants, meeting once weekly for 10-12 sessions of 2 hours each.

Assessments will be conducted at baseline and post-treatment using the Yale-Brown Obsessive Compulsive Scale (Y-BOCS), Dimensional Obsessive-Compulsive Scale (DOCS), Vancouver Obsessional Compulsive Inventory (VOCI), SF-36 Quality of Life Scale, Acceptance and Action Questionnaire-II (AAQ-II), Hospital Anxiety and Depression Scale (HADS), and Toronto Alexithymia Scale (TAS-20).

Enrollment

36 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of Obsessive-Compulsive Disorder according to DSM-5 criteria
  • Age between 18-65 years
  • Minimum literacy level
  • Willingness to participate and providing informed consent

Exclusion criteria

  • Age over 65 years
  • Diagnosis of alcohol or substance use disorder
  • Comorbid psychotic disorder or intellectual disability
  • Any change in psychiatric treatment (medication or psychotherapy) in the last 3 months
  • Comorbid psychiatric disorder that would impair group therapy compliance
  • History of cognitive impairment due to dementia, organic brain syndrome or other neurological/organic pathology

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

36 participants in 2 patient groups

ACT-Based Group Psychotherapy
Experimental group
Description:
Emotion-focused Acceptance and Commitment Therapy (ACT) based structured group psychotherapy targeting emotional awareness, acceptance, cognitive defusion, present-moment focus, values clarification and committed action. Groups consist of 8-10 participants, meeting once weekly for 10-12 sessions of 2 hours each.
Treatment:
Behavioral: Emotion-Focused Acceptance and Commitment Therapy (ACT) Group Psychotherapy
Supportive Group Psychotherapy
Active Comparator group
Description:
Unstructured supportive group psychotherapy aimed at providing emotional support, enhancing coping with stress and maintaining current functioning. Groups consist of 8-10 participants, meeting once weekly for 10-12 sessions of 2 hours each.
Treatment:
Behavioral: Emotion-Focused Acceptance and Commitment Therapy (ACT) Group Psychotherapy

Trial contacts and locations

1

Loading...

Central trial contact

Mehmet Emrah Karadere

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems